Buy & Sell Fidelity National Information Servcs Inc (FIS) – Fidelity National Information Servcs Inc Price Today
Key Stats
- $20.66BMarket Cap
- TechnologySector
- -21.61%3M Drawdown
- $41.06BEnterprise Value
- 4.2%Dividend Yield
- 49% Buy | 51% SellTrading Activity
- 88 daysTypical Hold Time
Fidelity National Information Servcs Inc (FIS) is currently valued at a market capitalization of $20.66B, with an enterprise value of $41.06B. Over the past 52 weeks, Fidelity National Information Servcs Inc has traded between a low of $38.95 and a high of $82.35, highlighting its annual price range. Over the past three months, Fidelity National Information Servcs Inc has recorded a drawdown of -21.61%, reflecting recent price volatility. Fidelity National Information Servcs Inc offers a dividend yield of 4.2%, with the most recent dividend of $0.44 paid on 10 Mar 26. On average, investors hold Fidelity National Information Servcs Inc for approximately 88 days, indicating typical investor behavior on the platform.
About Fidelity National Information Servcs Inc
Fidelity National Information Services' legacy operations provide core and payment processing services to banks, but its business has expanded over time. By acquiring Sungard in 2015, the company now provides record-keeping and other services to investment firms. With the acquisition of Worldpay in 2019, FIS now provides payment processing services for merchants and holds leading positions in the United States and United Kingdom. About a fourth of revenue is generated outside North America.
Most Recent News
ConocoPhillips director sells shares amid oil price drop and rising supply concerns
A director at ConocoPhillips sold 1,974 shares worth about $235,000 following a 2.2% drop in the company's stock price amid a broader oil market downturn. The decline in oil prices was driven by increasing global supply, with key indicators like Bren...
Global Initiative on Loneliness and Connection hosts forum to tackle social division and loneliness worldwide
The Global Initiative on Loneliness and Connection (GILC) convened the 2026 Global Connection Forum on June 17 to address the growing public health crisis of loneliness and social isolation, which contribute to serious health risks and societal divis...
Metastatic prostate cancer market to grow strongly through 2036 with new targeted therapies emerging.
The metastatic prostate cancer market is shifting from traditional hormone therapies to precision, biomarker-driven treatments, including novel PARP inhibitors and PSMA-targeted radioligand therapies. The market, valued at $11.5 billion in 2025 in ma...
